Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
Titel:
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial
Auteur:
Corrie, P.G. Marshall, A. Nathan, P.D. Lorigan, P. Gore, M. Tahir, S. Faust, G. Kelly, C.G. Marples, M. Danson, S.J. Marshall, E. Houston, S.J. Board, R.E. Waterston, A.M. Nobes, J.P. Harries, M. Kumar, S. Goodman, A. Dalgleish, A. Martin-Clavijo, A. Westwell, S. Casasola, R. Chao, D. Maraveyas, A. Patel, P.M. Ottensmeier, C.H. Farrugia, D. Humphreys, A. Eccles, B. Young, G. Barker, E.O. Harman, C. Weiss, M. Myers, K.A. Chhabra, A. Rodwell, S.H. Dunn, J.A. Middleton, M.R. Nathan, Paul Lorigan, Paul Dziewulski, Peter Holikova, Sonja Panwar, Udaiveer Tahir, Saad Faust, Guy Thomas, Anne Corrie, Pippa Sirohi, Bhawna Kelly, Charles Middleton, Mark Marples, Maria Danson, Sarah Lester, James Marshall, Ernest Ajaz, Mazhar Houston, Stephen Board, Ruth Eaton, David Waterston, Ashita Nobes, Jenny Loo, Suat Gray, Gill Stubbings, Helen Gore, Martin Harries, Mark Kumar, Satish Goodman, Andrew Dalgleish, Angus Martin-Clavijo, Agustin Marsden, Jerry Westwell, Sarah Casasola, Richard Chao, David Maraveyas, Anthony Marshall, Ernest Patel, Poulam Ottensmeier, Christian Farrugia, David Humphreys, Alison Eccles, Bryony Dega, Renata Herbert, Chris Price, Christopher Brunt, Murray Scott-Brown, Martin Hamilton, Joanna Hayward, Richard Larry Smyth, John Woodings, Pamela Nayak, Neena Burrows, Lorna Wolstenholme, Virginia Wagstaff, John Nicolson, Marianne Wilson, Andrew Barlow, Clare Scrase, Christopher Podd, Timothy Gonzalez, Michael Stewart, John Highley, Martin Wolstenholme, Virginia Grumett, Simon Goodman, Andrew Talbot, Toby Nathan, Kannon Coltart, Robert Gee, Bruce Gore, Martin Farrugia, David Martin-Clavijo, Agustin Marsden, Jerry Price, Christopher Farrugia, David Nathan, Kannon Coltart, Robert Nathan, Kannon Coltart, Robert